Growing community of inventors

Bergisch Gladbach, Germany

Thomas Fahrig

Average Co-Inventor Count = 4.67

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 20

Thomas FahrigIrene Gerlach (3 patents)Thomas FahrigReinhard Jork (2 patents)Thomas FahrigErvin Horváth (2 patents)Thomas FahrigJoachim Schuhmacher (1 patent)Thomas FahrigKai Thede (1 patent)Thomas FahrigNicole Diedrichs (1 patent)Thomas FahrigJaques Ragot (1 patent)Thomas FahrigErvin Horváth (1 patent)Thomas FahrigIrene Gerlach (0 patent)Thomas FahrigThomas Fahrig (3 patents)Irene GerlachIrene Gerlach (5 patents)Reinhard JorkReinhard Jork (10 patents)Ervin HorváthErvin Horváth (9 patents)Joachim SchuhmacherJoachim Schuhmacher (51 patents)Kai ThedeKai Thede (34 patents)Nicole DiedrichsNicole Diedrichs (15 patents)Jaques RagotJaques Ragot (1 patent)Ervin HorváthErvin Horváth (1 patent)Irene GerlachIrene Gerlach (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Bayer Aktiengesellschaft (2 from 12,157 patents)

2. Bayer Healthcare Aktiengesellschaft (1 from 76 patents)

3. Intermed Discovery Gmbh (0 patent)


3 patents:

1. 8030347 - Cylopenta[b]benzofuran derivatives and the utilization thereof

2. 6331561 - Use of substituted amino-methyl-chromans for the prevention of neuronal degeneration and for the promotion of neuronal regeneration

3. 6235774 - Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…